GlaxoSmithKline Pharmaceuticals Ltd reported an 18% revenue increase to ₹946 crore for Q3 ended December 31, 2024, with a Profit After Tax of ₹229 crore, as announced on February 14.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback